In one click
The discovery of EVs as natural carriers of functional small molecules and proteins has raised great interest in the drug delivery field as it may be possible to harness these vesicles for the therapeutic delivery of peptides and synthetic drugs. As well as, the development of new EV related technologies that haven’t been used until now.
The metabolic attributes of natural source EVs are actively researched worldwide to address strategic priorities from sustainable sources. This project will contribute to national and EU research agendas providing a new EU perspective on frontier biotechnology, translation fundamental work outputs into market-led opportunities relevant to the nanomedicine, cosmetic and nutraceutics sectors.